| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_527cbadc3d8cf81b5bf931c0dd99b3c1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6491 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| filingDate |
1996-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a35c1e3de69ece949f7139848b000322 |
| publicationDate |
1998-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5843695-A |
| titleOfInvention |
Method for decomposing amyloid protein precursor and amyloid β-protein |
| abstract |
The present invention relates to a βAP decomposing agent or a medicine for preventing and curing Alzheimer's disease, which contains, as the active ingredient, gelatinase A, a limited decomposate of gelatinase A, progelatinase A, a complex to which any of them has bonded or a material containing any of them. βAP is a substance which is considered to cause Alzheimer's disease. |
| priorityDate |
1993-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |